on "restricted" status in 36.4% of hospitals. Guidelines for care of patients with ADHF were used in the emergency department (ED), inpatient care units, and outpatient clinics in 18.6%, 43.0% and 8.5% of hospitals respectively. Overall, ADHF care including general treatment as well as specific use of nesiritide was deemed to be appropriate in the majority of patients but nearly twice as many respondents perceived the management of ADHF and specific use of nesiritide was inappropriate in ED compared to the inpatient treatment. Only 41.1% of the respondents reported following Braunwald recommendations for the use of nesiritide. CONCLUSION: A sizable percentage of responding community hospitals did not have guidelines for treatment of ADHF despite existence of such in the literature. There are potential opportunities for improvement in the general treatment of ADHF as well as use of nesiritide in ADHF especially in the ED or observation unit versus inpatient. AstraZeneca LP, Wilmington, DE, USA OBJECTIVES: To evaluate outcomes of clopidogrel use following hospitalization for ACS in patients who had stent placement during the index hospitalization. METHODS: Retrospective administrative claims data from a geographically diverse US managed care organization (MCO) were used to identify patients ≥ 18 years of age, hospitalized with ACS diagnoses, treated with stent placement, and filling clopidogrel prescriptions within 7 days of discharge between 2000 and 2004 using ICD-9, CPT-4, and NDC codes. Exclusion criteria included ACS, anticoagulant or antiplatelet therapy 12 months prior to the index event, and use of anticoagulant or antiplatelet agents except aspirin and clopidogrel in the follow-up period. Clopidogrel exposure and non-exposure time following the index hospitalization were determined based on prescription data. Outcomes: Hospitalization for ischemic events (IE) and hospitalization or ER visits for bleeding episodes (BE) were determined using ICD-9 codes. Cox proportional-hazard regression controlled for clopidogrel exposure, age, gender, diabetes, hypertension, percutaneous transluminal coronary angioplasty (PTCA), and coronary artery bypass graft (CABG). RESULTS: A total of 9129 subjects, 79.5% male, mean age 54.6 ± 9 years, were identified. Mean follow-up time was 514 days, mean clopidogrel exposure time was 210 days, and mean non-exposure time was 303 days. IE rate was 8.7% during exposure and 9.1% during non-exposure; BE rates were 0.8% and 0.7%, respectively. Hazard ratio (HR) for IE during clopidogrel exposure was 0.87 [95% CI, 0.78-0.96; P = 0.007]. Other significant HRs were male gender (0.79; P < 0.001); diabetes (1.32; P < 0.001); and hypertension (1.13; P < 0.017). HR for BE during clopidogrel exposure was 1.46 [95% CI, 1.09-1.97; P = 0.012]; other significant HRs were hypertension (1.35; P = 0.041) and age (1.04; P < 0.001). CONCLUSION: This confirms clinical study findings that clopidogrel use reduces subsequent IE in ACS patients treated with stent placement, with a bleeding risk comparable to that observed in the CURE study. Longer treatment with clopidogrel could potentially reduce additional IE.
CARDIOVASCULAR STUDIES-Methods

PCV60 THE CLIN-O-GRAM: A GRAPHICAL TOOL DESCRIBING DRUG USE PRIOR TO CLINICAL OUTCOMES
Gause D, Preblick R, Levy D, Raghavan K Novartis Pharmaceuticals, East Hanover, NJ, USA OBJECTIVES: To illustrate a graphical approach for summarizing patterns of drug use and resource utilization surrounding clinical outcomes. METHODS: Partitioned bar charts, displayed on horizontal axis at times of clinical measurements, display percentages of patients taking different drug classes prior to each clinical measure. Superimposed on charts are plots of average clinical values, age, and duration/visits since diagnosis. Bootstrapping is used to provide confidence intervals for clinical and utilization estimates. RESULTS: The clin-o-gram will be illustrated using demographic, prescription, and longitudinal blood pressure measurments on hypertensive patients from the General Electric Electronic Medical Record captured in the Centricity Physician Office system. The descriptive clin-o-gram plots provide clues for subsequent inferential analysis including marginal mean and pooled logisitc regression over vists. CONCLU-SION: With increased availability of clinical outcomes comes need to visualize patterns of drug use relative to changes in the outcomes. Statistical models of changing clinical measures as function of changing drug utilization need to be preceded by graphical summaries.
PCV61 DIFFERENCES IN ANTIBIOTICS PRESCRIBED BY PHYSICIANS WITH HIGH AND LOW INFECTION RATES APPLIED TO PATIENTS UNDERGOING CARDIOVASCULAR SURGERY
Cerrito PB 1 , Cerrito JC 2 1 University of Louisville, Louisville, KY, USA, 2 Kroger Pharmacy, Louisville, KY, USA OBJECTIVES: To investigate patterns in antibiotic prescribing for patients undergoing cardiovascular surgery to determine whether there are differences between physicians with high rates of infection compared to physicians with low rates of infection. METHODS: All cardiovascular surgeries from a mid-sized southern hospital over a 2-year period were examined (approximately 2100 surgeries). A cross-tabulation between physician and patient infections was performed to identify those physicians with a low (under 6%) and a high (over 6%) infection rates. Information from the pharmacy database relating to all patients in the cardiovascular database was extracted, and all antibiotic prescriptions were identified. The data mining techniques of association rules and kernel density estimation were used to investigate prescribing patterns between the two groups of physicians. RESULTS: While the surgeons did not seem to differ in their use of cephalosporins, they differed considerable in their use of fluoroquinolones. Low infection physicians made more frequent use of Cipro while high infection physicians tended to make more use Levaquin. In addition, some patients received up to eight different antiobiotics as inpatients before, during, and after cardiovascular surgery. CONCLUSION: Data mining techniques that have been developed for business applications can be used to investigate physician decisions and their impact on patient outcomes. Variability in physician decisions in the absence of treatment guidelines can be investigated observationally, and meaningful results obtained. In this application, there are differences in antibiotic use related to infection rates. These differences should be examined and a consensus reached for prescribing habits.
